S. Wittig

发表

Identification of a Set of Seven Genes for the Monitoring of Minimal Residual Disease in Pediatric Acute Myeloid Leukemia

I. Pastan, A. Rump, D. Steinbach, 2006, Clinical Cancer Research.

Mesothelin, a possible target for immunotherapy, is expressed in primary AML cells

I. Pastan, D. Steinbach, B. Gruhn, 2007, European journal of haematology.

PRAME expression is not associated with down-regulation of retinoic acid signaling in primary acute myeloid leukemia.

D. Steinbach, B. Gruhn, S. Wittig, 2007, Cancer genetics and cytogenetics.

The multidrug resistance-associated protein 3 (MRP3) is associated with a poor outcome in childhood ALL and may account for the worse prognosis in male patients and T-cell immunophenotype.

D. Steinbach, B. Gruhn, F. Zintl, 2003, Blood.

Messenger RNA Analysis of the Multidrug Resistance Related Protein (MRP1) and the Lung Resistance Protein (LRP) in de novo and Relapsed Childhood Acute Lymphoblastic Leukemia

F. Zintl, S. Wittig, A. Voigt, 2002, Leukemia & lymphoma.

The histone deacetylase inhibitor vorinostat induces calreticulin exposure in childhood brain tumour cells in vitro

J. Beck, M. Schmudde, S. Wittig, 2010, Cancer Chemotherapy and Pharmacology.

Are MTT assays the right tool to analyze drug resistance caused by ABC-transporters in patient samples?

D. Steinbach, B. Gruhn, F. Zintl, 2005, Leukemia & lymphoma.

Adiponectin serum concentrations in newborn at delivery appear to be of fetal origin

E. Schleußner, J. Beck, K. Dawczynski, 2014, Journal of pediatric endocrinology & metabolism : JPEM.

Association of recipient and donor interleukin 6 polymorphisms 174 and 597 with outcome after allogeneic hematopoietic stem cell transplantation in children

B. Gruhn, S. Wittig, Laura Wetzel, 2021, Journal of Cancer Research and Clinical Oncology.

Reverse chemomodulatory effects of the SIRT1 activators resveratrol and SRT1720 in Ewing’s sarcoma cells: resveratrol suppresses and SRT1720 enhances etoposide- and vincristine-induced anticancer activity

O. Krämer, J. Beck, M. Kahl, 2015, Journal of Cancer Research and Clinical Oncology.

Polymorphisms of Dectin-1 and TLR2 Predispose to Invasive Fungal Disease in Patients with Acute Myeloid Leukemia

S. Scholl, B. Gruhn, A. Hochhaus, 2016, PloS one.

Prognostic impact of WT1 expression prior to hematopoietic stem cell transplantation in children with malignant hematological diseases

B. Gruhn, S. Wittig, Clemens Arndt, 2015, Journal of Cancer Research and Clinical Oncology.

Expression of components of the IGF axis in childhood acute myelogenous leukemia

D. Steinbach, F. Zintl, K. Dawczynski, 2008, Pediatric blood & cancer.

Histone deacetylase inhibitor-mediated sensitization to TRAIL-induced apoptosis in childhood malignancies is not associated with upregulation of TRAIL receptor expression, but with potentiated caspase-8 activation

J. Beck, S. Wittig, J. Sonnemann, 2012, Cancer biology & therapy.

The sirtuin 1/2 inhibitor tenovin-1 induces a nonlinear apoptosis-inducing factor-dependent cell death in a p53 null Ewing’s sarcoma cell line

Zhao-Qi Wang, René Thierbach, H. Slevogt, 2018, Investigational New Drugs.

Molecular remission using three monoclonal antibodies followed by allogeneic bone marrow transplantation in an infant with refractory ALL

B. Gruhn, T. Ernst, S. Wittig, 2020, Annals of Hematology.

Identification of a Set of Seven Genes for the Monitoring of Minimal Residual Disease in Pediatric Acute Myeloid Leukemia.

D. Steinbach, B. Gruhn, F. Zintl, 2005 .

CTLA‐4 polymorphism rs231775: Influence on relapse and survival after allogeneic hematopoietic stem cell transplantation in childhood

B. Gruhn, T. Ernst, S. Wittig, 2019, European journal of haematology.

Heparanase polymorphisms: influence on incidence of hepatic sinusoidal obstruction syndrome in children undergoing allogeneic hematopoietic stem cell transplantation

B. Gruhn, S. Wittig, Clemens Arndt, 2015, Journal of Cancer Research and Clinical Oncology.

The expression of histone deacetylase 4 is associated with prednisone poor-response in childhood acute lymphoblastic leukemia.

M. Walther, B. Gruhn, J. Beck, 2013, Leukemia research.

Interleukin-10-592 polymorphism: impact on relapse and survival after allogeneic hematopoietic stem cell transplantation in children with hematological malignancies

B. Gruhn, S. Wittig, Laura Schwenk, 2021, Journal of Cancer Research and Clinical Oncology.

p53-dependent and p53-independent anticancer effects of different histone deacetylase inhibitors

O. Krämer, J. Beck, S. Wittig, 2013, British Journal of Cancer.

Anticancer effects of the p53 activator nutlin-3 in Ewing's sarcoma cells.

J. Beck, S. Wittig, A. Voigt, 2011, European journal of cancer.

Increased activity of histone deacetylases in childhood acute lymphoblastic leukaemia and acute myeloid leukaemia: support for histone deacetylase inhibitors as antileukaemic agents

B. Gruhn, J. Beck, S. Wittig, 2012, British journal of haematology.

RETRA exerts anticancer activity in Ewing's sarcoma cells independent of their TP53 status.

J. Hentschel, O. Krämer, J. Beck, 2015, European journal of cancer.

CTLA-4 polymorphisms: influence on transplant-related mortality and survival in children undergoing allogeneic hematopoietic stem cell transplantation

B. Gruhn, T. Ernst, S. Wittig, 2016, Journal of Cancer Research and Clinical Oncology.

Detection of relapse after hematopoietic stem cell transplantation in childhood by monitoring of WT1 expression and chimerism

B. Gruhn, S. Wittig, H. Kreyenberg, 2015, Journal of Cancer Research and Clinical Oncology.

Wilms tumor gene single nucleotide polymorphism rs16754 predicts a favorable outcome in children with acute lymphoblastic leukemia

B. Gruhn, T. Lehmann, S. Wittig, 2015, Journal of Cancer Research and Clinical Oncology.

Increased activity of histone deacetylases in childhood acute lymphoblastic leukaemia and acute myeloid leukaemia: support for histone deacetylase inhibitors as antileukaemic agents

B. Gruhn, J. Beck, S. Wittig, 2012, British journal of haematology.

The sirtuin 1/2 inhibitor tenovin-1 induces a nonlinear apoptosis-inducing factor-dependent cell death in a p53 null Ewing’s sarcoma cell line

Zhao-Qi Wang, René Thierbach, H. Slevogt, 2018, Investigational New Drugs.